Finance

Lists
HQY:NASDAQ
Healthequity Inc
USD 92,61
-0,47%
(-0,44) 1D
USD 92,61
0,00% (0,00)
After hours
Closed: 9 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HQY...
Open
USD 92,98
High
USD 93,96
Low
USD 92,02
Mkt. cap
7,66 mjd
Avg. vol.
998,94 k
Volume
555,91 k
P/E ratio
33,46
52-wk high
USD 107,62
52-wk low
USD 72,76
EPS
USD 2,77
Beta
0,24
Shares outstanding
82,72 m
No. of employees
3 k
Open
USD 92,98
High
USD 93,96
Low
USD 92,02
Mkt. cap
7,66 mjd
Avg. vol.
998,94 k
Volume
555,91 k
P/E ratio
33,46
52-wk high
USD 107,62
52-wk low
USD 72,76
EPS
USD 2,77
Beta
0,24
Shares outstanding
82,72 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
HealthEquity, Inc. is an American financial technology and business services company that is designated as a non-bank health savings trustee by the IRS. This designation allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with. As of July 31, 2022, HealthEquity managed 7.5 million HSA accounts, plus 7 million other consumer-directed benefits for total accounts of 14.5 million. Total HSA assets as of July 31, 2022 were $20.5 billion, including $13.1 billion of HSA cash and $7.4 billion of HSA investments. Wikipedia
About Healthequity Inc
CEOJon Kessler
Employees2,81 k
Founded01 Jan. 2002
HeadquartersDraper, Utah, Verenigde State van Amerika
SectorHealth care provider
Analyst ratings
Based on 9 analysts giving stock ratings to HQY in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HQY in the last 3 months.
Highest
Current USD 92,61
USD 142,00 (+53,33%)
Average
USD 118,89 (+28,38%)
Lowest
USD 105,00 (+13,38%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Maintained
USD 108,00
+16,6%
10/06/2026
Stan Berenshteyn
Wells Fargo
Buy
Reiterated
USD 125,00
+35%
09/29/2026
Peter Warendorf
Barclays
Buy
Reiterated
USD 115,00
+24,2%
09/18/2026
George Hill
Deutsche Bank
Buy
Reiterated
USD 142,00
+53,3%
08/31/2026
Alexander Paris
Barrington
Buy
Reiterated
USD 110,00
+18,8%
08/28/2026
Sean Dodge
BMO Capital
Buy
Maintained
USD 105,00
+13,4%
08/28/2026
David Larsen
BTIG
Buy
Maintained
USD 115,00
+24,2%
08/28/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
USD 125,00
+35%
08/28/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
USD 125,00
+35%
08/18/2026
Alexei Gogolev
J.P. Morgan
Buy
Reiterated
USD 123,00
+32,8%
06/25/2026
Constantine Davides
Citizens JMP
Buy
Maintained
USD 111,00
+19,9%
06/01/2026
David Roman
Goldman Sachs
Sell
Maintained
USD 88,00
-5%
05/29/2026
Daniel Perlin
RBC Capital
Buy
Reiterated
USD 100,00
+8%
03/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
USD 108,00
+16,6%
02/19/2026
Gregory Peters
Raymond James
Buy
Reiterated
USD 100,00
+8%
02/17/2026
Last report
27 Aug. 2026
Fiscal period
Q2 2027
USD 1,24 / USD 1,19
+3,91%beat
Revenue / Est. (USD)
350,73 m / 349,23 m
+0,43%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Okt. 2025
Jan. 2026
Apr. 2026
Jul. 2026
Revenue
322,16 m
334,59 m
354,64 m
350,73 m
Cost of goods sold
94,10 m
106,44 m
98,33 m
92,78 m
Cost of revenue
94,10 m
106,44 m
98,33 m
92,78 m
Research and development expenses
65,92 m
70,35 m
67,77 m
73,92 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,29 m
58,45 m
57,96 m
58,08 m
Operating expense
148,21 m
155,75 m
152,25 m
158,29 m
Total operating expenses
242,31 m
262,19 m
250,58 m
251,07 m
Operating income
79,85 m
72,40 m
104,07 m
99,66 m
Other non operating income
22,00 k
329,00 k
161,00 k
20,00 k
EBT including unusual items
67,53 m
60,90 m
92,41 m
87,86 m
EBT excluding unusual items
68,69 m
62,22 m
93,53 m
88,84 m
Income tax expense
15,84 m
11,16 m
23,00 m
22,22 m
Effective tax rate
23,46%
18,32%
24,88%
25,29%
Other operating expenses
-
-
-
-
Net income
51,69 m
49,74 m
69,42 m
65,64 m
Net profit margin
16,05%
14,87%
19,57%
18,72%
Earnings per share
1,01
0,95
1,24
1,24
Interest and investment income
2,86 m
2,77 m
1,89 m
1,76 m
Interest expense
-14,05 m
-13,27 m
-12,59 m
-12,60 m
Net interest expenses
-11,18 m
-10,50 m
-10,70 m
-10,84 m
Depreciation and amortization charges
-
-
-
-
EBITDA
118,63 m
111,08 m
142,28 m
141,62 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme